Top 50 Medical VC Funds & Investors in Sweden (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Almi Invest
VC Fund
|
13 | Sweden, United States, Ukraine | Seed, Pre-Seed | Software, Health Care, Information Technology | $174k–$2.2M |
|
Chalmers Ventures AB
VC Fund
|
11 | Sweden | Pre-Seed, Seed | Software, Biotechnology, Health Care | $5k–$2.7M |
|
Sciety
VC Fund
|
9 | Sweden, Ukraine | Seed, Series A | Health Care, Biotechnology, Medical | $128k–$6.3M |
|
Sweet Studio
VC Fund
|
4 | Sweden | Pre-Seed | iOS, Apps, Audio | $145k–$400k |
|
Hadean Ventures
VC Fund
|
4 | Norway, Sweden, Germany | Series A, Series B | Biotechnology, Health Care, Medical | $4.3M–$79M |
|
Partnerinvest Norr
VC Fund
|
3 | Sweden, United States | Seed, Series A | Software, Manufacturing, Information Technology | $588k–$5.3M |
|
Inventure
VC Fund
|
3 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Health Care | $549k–$23M |
|
Bonit Capital
VC Fund
|
3 | Sweden, United States, Germany | Seed, Series A | Health Care, Medical, Apps | $1.8M–$4.2M |
|
Crowberry Capital
VC Fund
|
3 | Iceland, Denmark, Finland | Seed, Series A, Pre-Seed | Software, Gaming, Health Care | $1k–$17M |
|
Norrsken VC
VC Fund
|
3 | Sweden, Germany, United Kingdom | Seed, Series A | Software, Health Care, Food and Beverage | $1.1M–$27M |
|
Life Science Invest
VC Fund
|
2 | Sweden | Seed | Biopharma, Biotechnology, Pharmaceutical | $1.8M–$4.6M |
|
Project A Ventures
VC Fund
|
2 | Germany, United Kingdom, United States | Seed, Series A, Series B | Software, E-Commerce, Information Technology | $1.5M–$75M |
|
Noaber
VC Fund
|
2 | The Netherlands, Israel, Sweden | Seed, Series A | Health Care, Medical, Fitness | $1.3M–$20M |
|
Nordic Science Investments
VC Fund
|
2 | Finland, Sweden | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Diagnostics | $380k–$4.6M |
|
Scale Capital
VC Fund
|
2 | Denmark, Norway, Sweden | Seed, Pre-Seed | Software, SaaS, Information Technology | $1M–$4.4M |
|
Otiva
VC Fund
|
2 | Sweden, France | Seed, Series A, Series B | Fashion, Lifestyle, Marketplace | $1.6M–$12M |
|
Industrifonden
VC Fund
|
2 | Sweden, United States, Denmark | Series A, Seed | Software, Biotechnology, Information Technology | $1.1M–$21M |
|
Metsa Spring
VC Fund
|
2 | Finland, Sweden | Seed, Series A | GreenTech, Sustainability, Chemical | $395k–$8.4M |
|
3T Invest
VC Fund
|
2 | Sweden | Seed, Series A | Medical, Health Care, Lifestyle | |
|
Index Ventures
VC Fund
|
2 | United States, United Kingdom, France | Series A, Series B, Seed | Software, E-Commerce, Internet | $1.3M–$100M |
|
Flerie Invest
VC Fund
|
2 | Sweden, United Kingdom, Israel | Series A, Series B | Health Care, Biotechnology, Medical | $2.5M–$75M |
|
Heartcore Capital
VC Fund
|
2 | Denmark, United States, Germany | Seed, Series A, Series B | Software, Artificial Intelligence, FinTech | $1.3M–$76M |
|
SEB Venture Capital
VC Fund
|
2 | Sweden, Denmark, United Kingdom | Series A, Series B | Software, Information Technology, FinTech | $1.2M–$23M |
|
Uppsala universitet Invest AB
VC Fund
|
2 | Sweden | Seed | Medical, Health Care, Health Diagnostics | $1.7M–$1.8M |
|
Karolinska
VC Fund
|
2 | Sweden, Denmark, United States | Seed, Series A | Biotechnology, Health Care, Pharmaceutical | $1.3M–$73M |
|
Novo Holdings
VC Fund
|
2 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $8M–$125M |
|
Jovitech Invest
VC Fund
|
2 | Sweden | Seed | Solar, Medical, Recycling | $395k–$1M |
|
Creandum
VC Fund
|
2 | Sweden, Germany, United States | Series A, Seed, Series B | Software, Information Technology, Artificial Intelligence | $1.8M–$88M |
|
Sting Capital
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Software, Apps, Medical | $216k–$724k |
|
GU Ventures
VC Fund
|
2 | Sweden | Seed, Series A | Medical, Health Care, Pharmaceutical | $810k–$2.9M |
|
Gamlegård Invest
VC Fund
|
1 | Sweden | Seed | Medical, Health Care | |
|
Add Health Media
VC Fund
|
1 | Sweden | Seed | Health Care, Medical, Apps | $660k–$1.4M |
|
Incos Invest
VC Fund
|
1 | Italy, Sweden | Seed, Convertible Note | Travel, Boating, Medical | |
|
Forbion Capital Partners
VC Fund
|
1 | United States, United Kingdom, The Netherlands | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $12M–$176M |
|
20 North Street
VC Fund
|
1 | Sweden | Medical, mHealth, Wireless | ||
|
Ferd
VC Fund
|
1 | Norway, Sweden, United States | Private Equity, Series A | Software, Energy, Information Technology | $2.2M–$14M |
|
Accel
VC Fund
|
1 | United States, India, United Kingdom | Series A, Series B, Seed | Software, SaaS, Information Technology | $1.5M–$70M |
|
Sunstone Life Science Ventures
VC Fund
|
1 | Denmark, Sweden, Switzerland | Series B, Series A | Biotechnology, Health Care, Medical | $5.5M–$52M |
|
Webrock Ventures
VC Fund
|
1 | Brazil, Sweden | Series A, Seed | Health Care, Marketplace, Business Intelligence | |
|
Icebreaker.vc
VC Fund
|
1 | Finland, Estonia, Sweden | Pre-Seed, Seed, Series A | Software, Information Technology, Artificial Intelligence | |
|
Nordic Foodtech VC
VC Fund
|
1 | Finland, Sweden, Denmark | Seed, Series A | Biotechnology, Life Science, Water | |
|
Tham Invest
VC Fund
|
1 | Sweden | Pre-Seed | Medical, Wellness, Health Care | |
|
Zentynel Frontier Investments
VC Fund
|
1 | United States, Sweden | Series A, Seed, Angel | Health Care, Baby, Fitness | |
|
Faro Capital
VC Fund
|
1 | Sweden, United States | Series A, Seed | Biotechnology, Gaming, Medical | |
|
SmiLe Inject Capital
VC Fund
|
1 | Sweden | Seed | Medical, Genetics, Analytics | |
|
Fåhraeus Startup and Growth
VC Fund
|
1 | Sweden | Seed | Medical, Health Care, Organic Food | |
|
KTH Holding
VC Fund
|
1 | Sweden | Seed, Pre-Seed | Software, Information Technology, Biotechnology | |
|
Walking Ventures
VC Fund
|
1 | United Kingdom, United States, Sweden | Seed, Series A, Angel | Software, Health Care, Internet | $170k–$13M |
|
Sweet Capital
VC Fund
|
1 | United States, United Kingdom, Israel | Seed, Series A | Apps, Software, Mobile | $1.8M–$32M |
|
HealthCap
VC Fund
|
1 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $5.7M–$88M |
| Access all 157 VC funds in Sweden Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science.We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions,industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress.With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik.Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network.Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Sweden, United States, Ukraine
Investor stats
- Total investments: 263
- Round size: Seed $174k–$2.2M; Pre-Seed $236k–$1.3M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Indevex AB — Indevex is a science-based and privately owned biotech company from Sweden. A natural and reliable partner, providing evidence based natural nutrition concepts based on the patented NGC™ Formula.
- Xaga Surgical — Xaga Surgical aims to minimize the risk of infections by inventing safer medical needles.
- Inhalation Sciences — The PreciseInhale patented aerosol generation R&D platform delivers respirable dry powder aerosols from preclinical cell studies all the way through to human clinical trials, significantly accelerating drug development timelines. The platform’s one-animal-at-a-time system requires just milligrams, not grams of costly test substance for a fullPK study and delivers high-resolution lung data of, typically, <10% SD. We carry out Contract Research for novel and generic inhalation drug developers, toxicology and environmental research institutes and university research institutes in the inhalation and aerosolization field.
We are a leading tech investor & venture builder in the Nordics. Taking deep tech from lab to market.WELCOMEINVESTMENTS
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Pre-Seed, Seed
- Geography: Sweden
Investor stats
- Total investments: 169
- Round size: Seed $289k–$2.7M; Pre-Seed $5k–$183k
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Embedl AB — Efficient Deep Learning by Deep Learning model optimization
- Repli5 — Enabling autonomous vehicles with synthetic data. We automate the creation of synthetic data and digital twins.
- Detecht — Looking for a motorcycle app for your upcoming trips? Download Detecht with built-in GPS, Navigation, Route suggestions and Crash Detection on App Store or Google Play Store
Whether you are an investor or entrepreneur, partner with Sciety to achieve impactful returns and elevate your life science business in the Nordics.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Sweden, Ukraine
Investor stats
- Total investments: 44
- Round size: Seed $128k–$2.3M; Series A $439k–$6.3M
- Lead/follow: 93% lead, 7% follow
Portfolio highlights
- Capitainer — Capitainer enables patients to collect their own volume-defined dried blood spot at home.Capitainer started in 2016. Their technology is a volumetric blood collection device that enables patients to conveniently and safely collect blood samples in the comfort of their own home, our technology is more accurate than today’s solutions. Capitaineroffers impressive cost and environmental savings for healthcare providers managing millions of conventional blood samples annually.
- SAGA Diagnostics — SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from a highly successful research group at Lund University, with a mission to improve precision cancer medicine,provide more accurate treatment monitoring, and improve patient survival using minimally-invasive liquid biopsy cancer testing services and kits.The SAGA team consists of renowned scientists, highly qualified staff and an experienced management team who work together to launch SAGA’s ultrasensitive services and products as part of the ongoing revolution in cancer research, drug development, and clinical diagnostics. SAGA’s proprietary tests can help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at an unprecedented sensitivity.
- Single Technologies — Founded in Stockholm, Sweden, with its long tradition in fiber optics, ultra-sensitive fluorescence spectroscopy and DNA sequencing, SINGLE’s ambition is to become the instigator of 3-D Sequencing.
We co-found companies, dedicating our in-house team of designers, developers, and marketers to bring ideas to life. With every venture we co-found, our mission is to advance the consumer experience across industries with world-class technology, data-informed design, and lots of heart. Are you an entrepreneur who shares our mission?
Show more...Investment focus
- Industry: iOS, Apps, Audio
- Stage:Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 6
- Round size: Pre-Seed $145k–$400k
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Koo! — Koo! is an audio based social networking service that let users record and listen to 1-minute audio clips called Koos.
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
- Stride Leadership — Stride is the revolutionary leadership product built to help become a confident leader. For too long, we’ve been taught that leadership is an elite act that’s linked to your job title. Now you hold leadership development in your hand, regardless of your age, job title, or seniority.With Stride, you’ll learn what it truly means to lead, and how todo it. We’ll bust common myths and you’ll discover which style of leadership is the best fit for you. Designed by leadership and design experts, Stride will help you learn the mindset required, the basics of leadership, and techniques for dealing with inevitable challenges. Whether you’re new to leadership or you’re a seasoned professional you’ll love learning and forming new habits with Stride.
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Norway, Sweden, Germany
Investor stats
- Total investments: 27
- Round size: Series A $4.3M–$79M; Series B $28M–$68M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $105M in 2021
Portfolio highlights
- Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
- Emergence Therapeutics — Emergence Therapeutics is a European biopharmaceutical company developing novel antibody-drug conjugates (ADC) to treat high-need cancers. Its lead program combines a highly specific antibody with optimized linker and payload technology to target Nectin-4 – an important target for a broad range of cancers which has been clinically validated as anADC target by enfortumab vedotin, now approved for the treatment of urothelial cancers by the US Food and Drug Administration. Emergence is also actively exploring opportunities to develop further first- or best-in-class ADCs driven by therapeutic need.
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Partnerinvest Norr is a private equity firm specialized in software, security, and biometrics sectors. Partnerinvest Övre Norrland AB is a venture capital firms that seeks to invest in limited companies which have are in the expansion phase.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Series A
- Geography: Sweden, United States
Investor stats
- Total investments: 67
- Round size: Seed $588k–$2.1M; Series A $1.5M–$5.3M
- Lead/follow: 15% lead, 85% follow
- Last fund: May invest from a new fund soon — last raise in 2009
Portfolio highlights
- Senseworks — Senseworks is an insight platform that enables colleagues to collaborate effectively with customers by providing a single source of truth for accounting data.
- Cold River Games — Crystalfall is an upcoming free online action RPG with customizable skills and an endless endgame, set in a steampunk world.
- Remos Space Systems — Remos Space Systems simplifies satellite ground operations.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 164
- Round size: Seed $549k–$6M; Series A $1.3M–$17M; Series B $1.3M–$23M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $169M in 2022
Portfolio highlights
- Omocom — Omocom offers safe, simple and secure insurance for all kind of renting, sharing and re-using, digitally, automated and integrated into the sales flow of the platform
- Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
- Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
Bonit Capital is a Swedish family-owned investment company. We invest across sectors and asset classes, including social investments and outcome models.Venture Capital - We invest in ambitious founders within the life science sector. We take an active ownership approach by providing capital, industry expertise and access to an internationalnetwork. Our focus areas are digital health, medical technology and diagnostics.Private Equity - We invest in entrepreneurial teams with deep sector expertise and unique market access, primarily in the lower to mid-market buyout segment, with the aim to produce superior returns and meaningful portfolio diversification.Listed Equity - Our strategy is to obtain a broad market exposure through mainly external mandates, and to seek superior returns in individual shares primarily in life science. Among Bonit's main holdings are the world-leading medtech company Elekta AB, founded by Laurent Leksell.Leksell Social Ventures - LSV is the first impact investor in Sweden with a focus on outcome models and direct investments in the areas of mental health, education and social integration. Striving for systemic change, LSV contributes to social innovation and societal development by giving social entrepreneurs and social ideas the necessary prerequisites to develop and progress – through financing, idea development and networking with private, public and nonprofit actors.
Show more...Investment focus
- Industry: Health Care, Medical, Apps
- Stage:Seed, Series A
- Geography: Sweden, United States, Germany
Investor stats
- Total investments: 12
- Round size: Seed $1.8M–$4.2M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Vården.se — Vården.se is Sweden's largest private search service in healthcare and health .
- Bentley — Bentley engages in the development, manufacturing for minimal-invasive treatments of vascular diseases.
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.
Show more...Investment focus
- Industry: Software, Gaming, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Iceland, Denmark, Finland
Investor stats
- Total investments: 45
- Round size: Seed $1.6M–$4.7M; Pre-Seed $1k–$1.3M; Series A $5.7M–$17M
- Lead/follow: 51% lead, 49% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
- Hemi Health — Hemi Health is a Danish digital-first headache and migraine clinic specializing in diagnosis, personalized treatment, and care for headaches using technology like an app for symptom tracking and video consultations.
- Porcelain Fortress — Porcelain Fortress was founded by a small band of romantics in the summer of 2016 in Reykjavik, Iceland.
We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.
Show more...Investment focus
- Industry: Software, Health Care, Food and Beverage
- Stage:Seed, Series A
- Geography: Sweden, Germany, United Kingdom
Investor stats
- Total investments: 94
- Round size: Seed $1.1M–$11M; Series A $4.2M–$27M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $340M in 2024
Portfolio highlights
- Sunsave — Save money on your bills and gain energy independence with Sunsave solar panel and battery solutions. Get a free quote today.
- Ankar AI — Your AI Operating System for Patents
- Sava Technology — SAVA is reinventing health monitoring with a novel biosensing platform enabling real-time, affordable, and painless molecular monitoring.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!LSI Academy - New education 2026, read more here
Show more...Investment focus
- Industry: Biopharma, Biotechnology, Pharmaceutical
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 3
- Round size: Seed $1.8M–$4.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- AAX Biotech — AAX Biotech specializes in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. OurTechnologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics.Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies.
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
Project A is an early-stage venture capital firm, combining financial and operational support for technology companies. In addition to $1bn in assets under management, Project A provides its portfolio companies with a wide range of operational support services. This includes more than 100 experts from key areas such as software engineering,business intelligence, marketing, and recruiting. The portfolio includes companies such as Trade Republic, sennder, KRY, Catawiki, WorldRemit, Spryker, and Voi.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 204
- Round size: Seed $1.5M–$9.7M; Series A $3.8M–$28M; Series B $11M–$75M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Valve — Valve - the Global Industry System for Flexible Workspace
- Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
- Growblocks — Driving revenue growth is complicated. Teams need to collaborate, work with data and keep everyone on track in order to succeed.Growblocks strives to apply our winning formula to the B2B Scale-Up community helping our customers reach their revenue growth dreams - faster.We believe that when enough brains are applied, every problem is solvableand our team of brains is world class.Founded by a team of business leaders who have helped start, scale and exit some of the most successful SaaS companies in Europe. Funded by leading European VCs and Angel Investors.
Noaber Ventures invests in initiatives that bring social transformations using information technology.
Show more...Investment focus
- Industry: Health Care, Medical, Fitness
- Stage:Seed, Series A
- Geography: The Netherlands, Israel, Sweden
Investor stats
- Total investments: 19
- Round size: Seed $1.3M–$6.3M; Series A $3M–$20M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Plasmacure — Plasmacure develops innovative plasma technology for wound care. Discover how cold plasma is transforming the treatment of chronic wounds.
- Mirantus Health — Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients.
- Alba Health — Discover your baby's gut health & microbiome for the best start in life.
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Diagnostics
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden
Investor stats
- Total investments: 10
- Round size: Seed $1.1M–$4.6M; Pre-Seed $380k–$837k
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- AIATELLA — Automating medical image analysis
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
Scale Capital is an early-stage technology investor, helping Nordic, B2B, and tech founder teams scale and win in the US market.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Denmark, Norway, Sweden
Investor stats
- Total investments: 23
- Round size: Seed $1M–$4.4M
- Lead/follow: 52% lead, 48% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- All Gravy — Butter gives you happier employees, by reducing their financial stress and giving them an understanding of their salary and financial situation
- Players 1st — Join 3000 golf clubs using Players 1st to boost your business with pre-made surveys, smart analytics, and benchmarks, capturing real-time golfer feedback!
- Telescope — A practical tool for managing sustainability risk in real estate
Equity investment company doing Series A to late growth, private and public. Agile and long-term with no fixed holding period.
Show more...Investment focus
- Industry: Fashion, Lifestyle, Marketplace
- Stage:Seed, Series A, Series B
- Geography: Sweden, France
Investor stats
- Total investments: 8
- Round size: Seed $1.6M–$3.2M; Series A $3.2M–$12M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- BlaBlaCar — BlaBlaCar is the world’s leading long-distance carpooling community, connecting people looking to travel long distances with drivers going the same way. They travel together and share the costs of the journey. The platform is engineered to create a secure, trust-based community with declared identities and full member profiles. Members can evenspecify how chatty they are from “Bla” to “BlaBlaBla”, hence the name BlaBlaCar. BlaBlaCar is creating a global people-powered network with a trusted community of drivers and passengers.Backed by Accel Partners, Insight Ventures, Index Ventures, Lead Edge Capital, Baring Vostok and ISAI, it operates in 22 countries across Europe, Russia, Turkey, Mexico, Brazil and India. The site and free mobile apps provide a range of features to create a secure, trust-based community and easy connections between drivers and passengers.BlaBlaCar is based in Paris with offices across a dozen of countries.
- NA-KD.com — NA-KD.com is the next generation of fashion marketplaces. A predominantly mobile-based online shopping sanctuary for fashion addicts all over the world. Combined with a unique merchant service that unleashes the e-commerce power of digital brands and social influencers. Funded by the original founder and team behind Nelly.com (170 million USDonline fashion store).
- Pet Media Group — Woof Woof. Europe's Largest Pet Marketplaces PetMediaGroup is the leading operator of online marketplaces for pets and related goods and services. Through our trusted and local brands, we help thousands of animals every day to find a new loving home as well as assist their human caregivers
Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Series A, Seed
- Geography: Sweden, United States, Denmark
Investor stats
- Total investments: 174
- Round size: Seed $1.1M–$6.3M; Series A $3.3M–$21M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.
- Open Payments — Open Payments connects you to multiple banks through one single unified API. This removes the complexity and frictions of many diverse integrations
- Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
We boldly invest in and support promising startups and potential innovations that explore new uses for sustainably-grown Nordic wood.
Show more...Investment focus
- Industry: GreenTech, Sustainability, Chemical
- Stage:Seed, Series A
- Geography: Finland, Sweden
Investor stats
- Total investments: 12
- Round size: Seed $395k–$5.3M; Series A $4.4M–$8.4M
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- Adsorbi — Adsorbi use cellulose from the Nordic forest to help air purification companies to capture gaseous air pollutants.
- FineCell — FineCell is a sustainable cellulose microfibers provider that enables manufacturers to make new products with reduced carbon footprints and differentiated properties.The company's cellulose microfibers possess physical and chemical properties that differ from competing products and provide differentiated benefits for the users. It has beensupported by Vinnova (Sweden’s innovation agency) and EIT InnoEnergy.The Linköping, Ostergotlands Lan-based company was established in 2015 by Jonatan Henschen, Jonas Engstrand, Monica Ek, and Kloce Dongfang Li.
- Woodio — Woodio is a digital designing agency.
3T Invest started an interesting and fulfilling journey back in 2009. From the beginning they focused on the establishment of sustainable Venture Capital, supporting innovation and entrepreneurship. they are always committed to backing outstanding entrepreneurs with the necessary resources.
Show more...Investment focus
- Industry: Medical, Health Care, Lifestyle
- Stage:Seed, Series A
- Geography: Sweden
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Linkura — Linkura offers a Lifestyle Program focusing on actions.
- Werlabs — Werlabs is a Stockholm based medical technology company founded by Will Stoddart and Rickard Lagerqvist, a general practioner. Werlabs provides customers with health analysis via blood testing. The company’s aim is to give users the tools and information to take care of their health.
Index Ventures is an international venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security.
Show more...Investment focus
- Industry: Software, E-Commerce, Internet
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 1059
- Round size: Seed $1.3M–$12M; Series A $5M–$35M; Series B $10M–$100M
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — raised $117M in 2015
Portfolio highlights
- Anrok — Anrok automates sales tax compliance across your financial stack, so you can grow your SaaS business in any market.
- Personio — Personio is the Intelligent HR platform for companies from 10-5,000 employees, powering over 1 million people worldwide. Book your free demo today.
- Milestone Systems — See and know more with video technology. Milestone offers award-winning XProtect video management software, Arcules VSaaS, and BriefCam analytics.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Sweden, United Kingdom, Israel
Investor stats
- Total investments: 19
- Round size: Series A $2.5M–$21M; Series B $12M–$75M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- Nanologica — Nanologica combines unique know-how in the field of materials technology with a genuine interest in solving real problems in life science. The company works with nanoporous silica which has properties that are attractive in a wide variety of applications. In order to succeed, development work is carried out in close dialog with customers.Nanologica is unique in that it is a world leader in controlling the form, type of porosity and surface area of particles of silica. This competence can be used to produce particles that have the potential to solve problems in diverse application areas. The company’s core competency has been developed and expanded in twoareas of application in particular: drug delivery on the one hand and on the other chromatography, a technology used for the separation and purification of products on the market and in development.The starting point for Nanologica’s work is the material sciences, a field in which the company’s founder has developed and patented completely new materials. The initial research was based at Stockholm University and the Ångström laboratories atUppsala University.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
Heartcore Capital invests in companies re-enchanting the world through technology.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Series A, Series B
- Geography: Denmark, United States, Germany
Investor stats
- Total investments: 194
- Round size: Seed $1.3M–$12M; Series A $3.4M–$27M; Series B $9.6M–$76M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $250M in 2021
Portfolio highlights
- Kobaj — Online marketplace for wine
- TrapLight Games — A hard-hitting mobile game studio from Finland. Traplight is a premium mobile games studio with 10+ years of game development expertise at the highest level. Our ambition is to create world class, chart topping, scalable game services.
- Fast Travel Games — Fast Travel Games is a VR exclusive game developer and publisher, founded by industry leading veterans and behind acclaimed titles such as Apex Construct and Wraith: The Oblivion - Afterlife.
SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.
Show more...Investment focus
- Industry: Software, Information Technology, FinTech
- Stage:Series A, Series B
- Geography: Sweden, Denmark, United Kingdom
Investor stats
- Total investments: 70
- Round size: Series A $1.2M–$11M; Series B $2.2M–$23M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $300M in 1995
Portfolio highlights
- Apica — The Operational Data Fabric from Apica unifies and connects all your data using a revolutionary Active Observability architecture.
- MobileTag — Mobile Tag, the European leader in mobile barcode solutions, continues to innovate with the launch of its latest application: mobiletag Universal Reader and shopping.Mobile Tag is behind the creation of the flashcode, the standard 2D barcode used by operators in France. This type of Datamatrix barcode is used by the biggest companies indisplay, transportation, distribution, the pharmaceutical industry, and more.Mobile Tag has always tried to develop new technology from the consumer's point of view, and the mobiletag Universal Reader & shopping is no exception.The concept behind this application is to send, receive and share information and best prices to everyone and for everyone through all standardized barcodes.Scanning a barcode with your mobile phone is simply taking a picture of it with your phone, using the mobiletag application. Mobile tag is free!
- CorPower Ocean — CorPower Ocean AB was founded in 2009 to develop high efficiency Wave Energy Converters (WECs).CorPower's Wave Energy Converters deliver five times higher annual energy output per ton of device compared to previously known wave power solutions. The step-change improvement in performance and efficiency allows a Cost-of-Energy that cancompete with offshore wind. The products are currently in pilot with Iberdrola. CorPower has assembled a team with extensive experience in energy generation, design and manufacturing of production equipment, system engineering as well as the market expertise to allow us to continue transforming the technology of tomorrow into renewable energy applications of today.
Uppsala universitet Invest AB focuses on investment management, particularly in early-stage ventures. The company collaborates with researchers and students, providing financial support and strategic guidance for innovative projects. It aims for long-term investment horizons, typically ranging from 5 to 15 years. Uppsala universitet Invest AB alsopartners with other investors and co-financiers to support research-driven initiatives.
Show more...Investment focus
- Industry: Medical, Health Care, Health Diagnostics
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 2
- Round size: Seed $1.7M–$1.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
- Readily Diagnostics — Readily Diagnostics develops speedy and accurate diagnostic tests for respiratory disorders, enabling faster and more effective therapy at the point of care.
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 26
- Round size: Series A $1.3M–$73M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- PharmNovo — Latest News from PharmNovo. Learn more about pain, neuropathic pain, chronic pain. Treatment with our lead candidate PN6047. Therapy market, our networks. There is a huge unmet medical need for people suffering from chronic pain.
- BOOST Pharma — Boost Pharma: Developing a stem cell therapy for Osteogenesis Imperfecta.
- Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 313
- Round size: Series A $8M–$100M; Series B $12M–$125M; Series C $30M–$115M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $165M in 2018
Portfolio highlights
- Hillstar Bio — Hillstar Bio is pioneering precision immunotherapies that target and deplete pathogenic immune cells, aiming to reset the immune system and transform treatment for autoimmune diseases.
- Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
- Bolt Biotherapeutics — Bolt is leveraging the immune system for a better way to treat cancer. Our approach works with a person's body, not against it.
Jovitech Invest help entrepreneur-led companies to grow profitably through active, long-term ownership
Show more...Investment focus
- Industry: Solar, Medical, Recycling
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 3
- Round size: Seed $395k–$1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Adsorbi — Adsorbi use cellulose from the Nordic forest to help air purification companies to capture gaseous air pollutants.
- Mat4Green Tech — Mat4Green Tech develops a technology that recycles Indium from industrial waste in an efficient and climate-neutral way.
We support early-stage founders in building global, category-defining companies. From Seed to IPO and beyond.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Sweden, Germany, United States
Investor stats
- Total investments: 264
- Round size: Seed $1.8M–$16M; Series A $5M–$30M; Series B $8M–$88M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- CAST AI — Kubernetes optimization platform for reliability and performance. CAST AI uses SLO signals to take guardrailed actions in production.
- Appcharge — Built for mobile gaming, we help publishers grow revenue and personalize every player interaction and checkout.
- atla — Advance the potential and safety of AI
Sting – Stockholm Innovation & Growth enables talented people to turn their ideas into sustainable businesses. The support they offer includes qualified coaching in business development, a business angel network, a venture capital fund, a recruitment service, and an international network of investors, business contacts and experts. Itcontribute to the success of Sweden’s future technology companies by helping them to grow and compete internationally.
Show more...Investment focus
- Industry: Software, Apps, Medical
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 16
- Round size: Seed $216k–$724k; Pre-Seed $366k–$611k
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Prion — Prion makes it quick and easy for the preschool staff to give parents insight into what happens at preschool - together with the children. The app is available free for iPhone, Android and iPad.
- Texelio — Texelio a company who is set to redefine financial market news by developing AI which empowers the customers of Retail banks, Online Brokers and Investment Service platforms.
- Minnemera — Minnemera develops digital neurocognitive tests.
GU Ventures build businesses out of groundbreaking ideas that help shape a better tomorrow. Our passionate team of company builders, financial experts, IP and legal talent ensure success for our companies.
Show more...Investment focus
- Industry: Medical, Health Care, Pharmaceutical
- Stage:Seed, Series A
- Geography: Sweden
Investor stats
- Total investments: 6
- Round size: Seed $810k–$2.9M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- NSS Water —
- Profundus Imaging — Profundus' retinal imaging technology enables researchers and clinicians in particular to visualise subclinical changes of retinal disease.
- Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Gamlegård Invest
Show more...Investment focus
- Industry: Medical, Health Care
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Linkura — Linkura offers a Lifestyle Program focusing on actions.
Add Health Media is a company that specializes in creating marketing materials for health companies.
Show more...Investment focus
- Industry: Health Care, Medical, Apps
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 13
- Round size: Seed $660k–$1.4M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Geras Solutions — Geras Solution’s mission is to be a leading provider of digital healthcare solutions.
- Migränhjälpen — Migränhjälpen is providing digital health services.
- Health Integrator — Health Integrator is a digital marketplace for access to health services. The Health Integrator health platform provides easy access to a large number of activities and health services gathered in one place.
Incos Invest is a venture capital firm specializing in start-up and early-stage investments. The firm seeks to make investments in companies operating in the industries of cosmetics, perfumes, travel and tourism, real estate, e-commerce, IT, and software development. The company is headquartered in Skane Lan, Sweden.
Show more...Investment focus
- Industry: Travel, Boating, Medical
- Stage:Seed, Convertible Note
- Geography: Italy, Sweden
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Antlos — Antlos is a peer-to-peer online marketplace that offers all-inclusive experience-driven boat holidays, published and managed directly by local Skippers, who are the captains and owners of the boat. Based on the principles of a Sharing Economy, Antlos makes yachting simple, affordable and accessible to everyone.Every Skipper may publish severallistings and be contacted by registered users willing to book a holiday. Guests can choose from different destinations and experiences offered and safely pay online via credit card, Paypal and Bank Wire. The Skippers can start earning from the rental of their boat without having to pay any agency fees and clients can book their holidays easily and safely thanks to Antlos' flexible cancellation policies and clear terms and conditions.Antlos was born in Venice and grown in H-FARM Campus. The team is composed of young professionals, passionate and expert on travel and the maritime industry, coming from different work experiences. Recently Antlos has been merged with the Swiss company which runs Sailogy.com.
- Joint Academy — Joint Academy connects patients with licensed physical therapists to deliver online treatments for chronic joint and back pain. Our treatments are clinically proven and give patients access to a personal, licensed physical therapist, an individualized exercise plan, interactive education about the condition, and progress tracking — all through auser-friendly app. Peer-reviewed studies show that Joint Academy patients reduce their pain, change their minds about surgery, and quit painkillers. Joint Academy is now available to patients in Sweden, the US, the UK, France, and Germany.
Impacting the future of medicine.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 171
- Round size: Series A $14M–$176M; Series B $12M–$155M; Series C $12M–$113M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- F2G — F2G is a biopharmaceutical company developing novel therapies for life-threatening fungal infections.
- Noema Pharma — DRIVING BETTER OUTCOMES Advancing therapeutics designed to deliver superior clinical benefit across both orphan and broader neurology indications Who we are ...
- Orbis Medicines — Orbis Medicines is a novel macrocyclic chemistry and computational platform for high-throughput drug discovery.
20 North Street is the name HDR Partners uses when adding investors and industrial experience to small growth companies.
Show more...Investment focus
- Industry: Medical, mHealth, Wireless
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Coala Life — Coala Life is a Swedish medical technology and life science company that focuses on heart diagnostics and digital health. The company has developed a portfolio of solutions based on the Coala, a patented and commercial service for remote monitoring and self-screening of heart sounds and ECG. The Coala is available direct to consumers and theCoala Pro is offered to healthcare professionals to enable smart, digital cardiac assessments.
Ferd er et familieeid investeringsselskap som er eid av femte og sjette generasjon Andresen.
Show more...Investment focus
- Industry: Software, Energy, Information Technology
- Stage:Private Equity, Series A
- Geography: Norway, Sweden, United States
Investor stats
- Total investments: 58
- Round size: Series A $2.2M–$13M; Private Equity $11M–$14M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — last raise in 2005
Portfolio highlights
- wheel.me — The first and only autonomous wheel in the world. The innovation transforms anything into an autonomous mobile robot with minimal effort and without the need to alter its design or form. The company was founded in 2013 and is headquartered in Oslo, Norway.
- Nofence — Manage your livestock from anywhere with GPS collars and a simple app. Unlock more acres, cut fencing costs, and run your operation on your terms.
- Kvist Solutions — Kvist Solutions tilbyr programvare som forenkler BREEAM sertifisering. Vi gir deg oversikt over hele prosjektet, slik at veien til sertifisering blir oversiktlig og forutsigbar.
First partner to exceptional teams everywhere
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Series A, Series B, Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1835
- Round size: Seed $1.5M–$10M; Series A $4.4M–$40M; Series B $9.5M–$70M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $14M in 2019
Portfolio highlights
- Polars — DataFrames for the new era
- QMC Telecom — QMC Telecom provides tower for carriers that offer wireless cellular telecommunication services in Puerto Rico. The company was formerly known as QMC Telecom International Holdings Group, LLC. The company was incorporated in 2011 and is based in Sao Paulo, Brazil, with an additional office in San Juan, Puerto Rico.
- Shift Technology — Shift Technology delivers AI-native decision automation and optimization solutions built specifically for the global insurance industry. Addressing several critical processes across the insurance policy lifecycle, Shift helps insurers achieve faster, more accurate claims and policy resolutions. Shift has analyzed billions of insurance transactionsto date and was presented Frost & Sullivan’s 2020 Global Claims Solutions for Insurance Market Leadership Award.
Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: Denmark, Sweden, Switzerland
Investor stats
- Total investments: 55
- Round size: Series A $5.5M–$43M; Series B $9.6M–$52M
- Lead/follow: 15% lead, 85% follow
- Last fund: May invest from a new fund soon — raised $94M in 2019
Portfolio highlights
- Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
- Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
We are a team of entrepreneurs and investment professionals, building digital platforms to empower Brazilians. Since 2016, we have partnered with leading Swedish technology companies to build, invest and support successful companies in Brazil.
Show more...Investment focus
- Industry: Health Care, Marketplace, Business Intelligence
- Stage:Series A, Seed
- Geography: Brazil, Sweden
Investor stats
- Total investments: 7
- Lead/follow: no public data
Portfolio highlights
- ViBe Saúde — Brazil's #1 Digital Health App. Telemedicine + Digital Therapeutics + Health & Wellness.
- Doktor.se — Doktor.se is a modern and personal care company working with digital healthcare. They are in an expansive phase, they have several offices in Sweden and grow sharply.With experienced specialist nurses, doctors and psychologists, they help their members to get quick and effective care. Their goal is to deliver a whole new level of service withinSwedish care.They help with counseling, book doctor hours, distance care, recipes, referrals, and much more. They always follow every case through their app. They also provide exclusive care and health offers as well as collecting interesting articles and news that will suit the clients.Doktor.se is an approved healthcare provider its counseling and booking are carried out by certified healthcare professionals and specialists in their area. Doktor.se also owns physical primary care and has extensive experience in Swedish healthcare.
- FinanZero — FinanZero is the leading online marketplace for consumer loans in Brazil. The business is an independent broker for loans, negotiating the customer’s loan application with several banks and credit institutions, to find the loan with the best interest rate and terms for the consumer. FinanZero handles the lending process from start to finish.FinanZero has more than 50 lending partners connected to its platform.The company was founded in 2015 and is based in São Paulo, Brazil.
Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Pre-Seed, Seed, Series A
- Geography: Finland, Estonia, Sweden
Investor stats
- Total investments: 121
- Lead/follow: no public data
Portfolio highlights
- Lutso — Empowering older adults to live independently, safely, and with dignity. Lutso is the smarter way to support aging at home.
- Cytely — Transforms microscopy from image-driven to data-driven through AI-powered autonomous targeting that captures high-resolution data of critical cellular events, enabling researchers to solve complex biological problems in minutes instead of years.
- NROC Security — Prevent data leaks, govern shadow AI, prove compliance, and save 50% on GenAI subscriptions
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food
Show more...Investment focus
- Industry: Biotechnology, Life Science, Water
- Stage:Seed, Series A
- Geography: Finland, Sweden, Denmark
Investor stats
- Total investments: 26
- Lead/follow: no public data
Portfolio highlights
- EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
- Endless Food — Endless Food Co is a food innovation firm focusing on the junction of pleasure and sustainability. Endless Food Co was pulled together by a common idea that the transition to a greener and more egalitarian future food system will be driven by flavor, and having spent the last decade pioneering sustainable gastronomy
- Happy Plant Protein — Revolutionize plant protein production with Happy Plant Protein's innovative technology, transforming local ingredients into high-quality, sustainable solutions for the food industry.
Tham Invest is an investment firm.
Show more...Investment focus
- Industry: Medical, Wellness, Health Care
- Stage:Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Letterlife — Letterlife is a unique tool and community designed to empower and support females with ADHD.The platform offers a range of resources and support, including coaching, online courses, and a community forum where women can connect with others who share similar experiences. Through Letterlife, women with ADHD can learn strategies to manage theirsymptoms, gain confidence, and build a strong sense of community.
Zentynel Frontier is a investment firm.
Show more...Investment focus
- Industry: Health Care, Baby, Fitness
- Stage:Series A, Seed, Angel
- Geography: United States, Sweden
Investor stats
- Total investments: 11
- Lead/follow: no public data
Portfolio highlights
- Asclepii — Multi-dimensional Wound Healing | Cell therapy is the future of human health. | Regenerative medicine for modern wound care.
- BIOMAKERS — BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.
- MultiplAI Health — Universal genomic screening for virtually any complex diseases, including cardiovascular disorders and cancer.
FARO is an Argentina company over 10 years of experience in the development and operation of integrated projects in the agribusiness sector. All projects FARO own position it as a reference and leader both locally and internationally.Among his various projects, FARO operates the largest tree planting pecan nut Latin America, with projection tobecome the largest southern hemisphere and one of the largest in the world. This project is structured under different vehicles, including Alto Pecan stands, the first real estate development of nautical fields planted with pecan nut Latin America, located in Villa Paranacito, Entre Ríos . Another project is AgroConsortium, productive trust for the production and marketing of cereals and oilseeds in leased farms located in different productive areas in Argentina and potentially in the region. Finally, thanks to the expertise acquired in agribusiness, FARO developed his own business model for productive land conversion. Its aim is to position rural properties whose productive potential is not reflected in the price and complement the cycle with the economic use of land in intensive production, short and medium term.Since 2006, the Investor Group is a strategic partner OMBU FARO for all investment portfolios development ventures related to agribusiness, that focus on supply both local and international markets.
Show more...Investment focus
- Industry: Biotechnology, Gaming, Medical
- Stage:Series A, Seed
- Geography: Sweden, United States
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
- Bluwhale — Unlock Web3 Wallet Potential with AI Insights. Supercharge Your Business Growth
- IntuiCell — IntuiCell develops a fundamentally new recursive computing architecture and associated technology platform.
SmiLe Inject Capital is an angel investment company to focus exclusively on early-stage life science companies.
Show more...Investment focus
- Industry: Medical, Genetics, Analytics
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Nygen Analytics — Nygen empowers researchers to unlock insights from single-cell RNA-seq data with accessible, no-code solutions, facilitating reproducible transcriptomic research.
Fåhraeus Startup and Growth is a venture capital fund that invests early in life science and tech companies.
Show more...Investment focus
- Industry: Medical, Health Care, Organic Food
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- Aplagon — Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
- Airsonett — The Airsonett AIR-4 is a mobile air cleaner intended to remove airborne particles and allergens from the breathing zone using temperature-controlled laminar airflow (TLA) technology. The device supports environmental control for individuals sensitive to airborne particles and allergens, including those affected by allergic conditions such as allergic asthma, allergic rhinitis, or atopic dermatitis. For home use.
- Nygen Analytics — Nygen empowers researchers to unlock insights from single-cell RNA-seq data with accessible, no-code solutions, facilitating reproducible transcriptomic research.
KTH Holding is a state-owned limited company managed by KTH's University Board. It invests in promising startup companies that are based on research or teaching at KTH, with the aim of supporting commercialization and making it easier for new science to benefit society.
Show more...Investment focus
- Industry: Software, Information Technology, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 22
- Lead/follow: no public data
Portfolio highlights
- Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.
- porkchop — In-space logistics for SmallSats in Low Earth Orbit and beyond.
- Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.
Walking Ventures is a seed fund which invests in early-stage Internet and other technology startups based in Europe. The fund is a private vehicle controlled by Tim Jackson, a leading figure in the European technology scene as a venture capitalist, entrepreneur, angel investor, commentator and technology journalist.
Show more...Investment focus
- Industry: Software, Health Care, Internet
- Stage:Seed, Series A, Angel
- Geography: United Kingdom, United States, Sweden
Investor stats
- Total investments: 27
- Round size: Seed $170k–$2.2M; Angel $273k–$917k; Series A $1.2M–$13M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Oviva — Oviva is digitizing the treatment of type 2 diabetes and obesity through a unique behavior change platform.They have developed unique, personalised behaviour change programmes that combine smartphone app and learning portals to support dietitian-led behaviour change for conditions such as type 2 diabetes and complex obesity. Their approach allowspatients to achieve a better health outcome without having to attend clinic appointments, whilst saving health systems significant sums by preventing the development of complications related to these health conditions.Oviva was founded in 2013 and is based in London, England.
- Tessian — Tessian enterprise email security protects employees from themselves. DLP and spear phishing protection. Automatically detect email threats.
- Articheck — We offer easy to use condition reports and complete visibility of art in-situ, transit and storage - avoid disputes, reduce liability, and protect artwork.
Sweet Capital is the private investment fund of the founders of King.com (Candy Crush Saga), following their $5.9b sale to Activision Blizzard in 2015 (ATVI:US; acq. MSFT:US).
Show more...Investment focus
- Industry: Apps, Software, Mobile
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 63
- Round size: Seed $1.8M–$5M; Series A $3M–$32M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Wellthy — Wellthy is a family care concierge service bringing relief to families managing complex or ongoing care situations. The company's solution brings relief to families managing aging-related concerns, childcare, special needs, health conditions, and other complex or ongoing care situations. Wellthy connects families with a dedicated CareCoordinator to help tackle the logistical and administrative tasks of caring for the ones they love, including themselves.Through Wellthy’s online platform, families can keep track of appointments, save contacts, organize tasks by type, store important documents, and revisit past conversations.The company was founded in 2014 by Lindsay Jurist-Rosner and Kevin Roche and is headquartered in New York, United States.
- Aula Education — Aula's created by educators to make every learning experience truly engaging. See how our simple, social platform can transform your digital learning environment.
- Immersive Gamebox — Electric Gamebox delivers immersive team Adventures in the world's smartest room. Our GameBox Adventure pods combine projection mapping, touch screen, motion tracking and surround sound technologies to create an entirely new form of digital group entertainment.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 121
- Round size: Series A $5.7M–$55M; Series B $14M–$88M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $209M in 2019
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
- Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Medical VC funding in Sweden at a glance
Stats across 178 deals from 157 investors.
Access all 157 VC funds in Sweden Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in Sweden investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 157 VC funds investing in Sweden Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!